Shopping Cart
Remove All
Your shopping cart is currently empty
SPDZi1 is a potent and selective inhibitor of syntenin, binding to the PDZ1 and PDZ2 domains of syntenin. It shows an affinity for the syntenin PDZ tandem (STNPDZ) with a dissociation constant (Kd) of 3.6 μM. Additionally, SPDZi1 inhibits glioblastoma and reduces the activity of NF-κB [a downstream effector of syntenin].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | SPDZi1 is a potent and selective inhibitor of syntenin, binding to the PDZ1 and PDZ2 domains of syntenin. It shows an affinity for the syntenin PDZ tandem (STNPDZ) with a dissociation constant (Kd) of 3.6 μM. Additionally, SPDZi1 inhibits glioblastoma and reduces the activity of NF-κB [a downstream effector of syntenin]. |
| In vitro | SPDZi1 (Z3322068027; 20 μM; 24 hours) inhibits the proliferation of human glioblastoma multiforme (GBM) cells and reduces NF-κB activation. In glioblastoma organoids (GBO), SPDZi1 effectively suppresses the growth of small GBOs. |
| Formula | C22H19N3O5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.